Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Structure-based drug design is the design and optimization ... s shallow catalytic pocket and non-specific substrate binding interactions. Here, the authors use Sulfur (VI) fluoride exchange ...
Aim: Drug–drug interactions (DDIs) are a widely recognized major cause of adverse drug reactions, but two other newly described important types of interactions also exist: drug–gene ...
Japan has been plagued by prolonged shortages of common drugs such as cough suppressants, expectorants and antimicrobial agents. According to a survey by a pharmaceutical industry organization ...